IN2014MU00198A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00198A
IN2014MU00198A IN198MU2014A IN2014MU00198A IN 2014MU00198 A IN2014MU00198 A IN 2014MU00198A IN 198MU2014 A IN198MU2014 A IN 198MU2014A IN 2014MU00198 A IN2014MU00198 A IN 2014MU00198A
Authority
IN
India
Prior art keywords
modified release
release tablet
pregabalin
stomach
drug
Prior art date
Application number
Other languages
English (en)
Inventor
Sehgal Ashish
Setty Umesh
Patel Nilesh
Original Assignee
Intas Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intas Pharmaceuticals Ltd filed Critical Intas Pharmaceuticals Ltd
Priority to PCT/IN2015/000032 priority Critical patent/WO2015114655A2/en
Priority to IN198MU2014 priority patent/IN2014MU00198A/en
Publication of IN2014MU00198A publication Critical patent/IN2014MU00198A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN198MU2014 2014-01-21 2015-01-20 IN2014MU00198A (enrdf_load_html_response)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2015/000032 WO2015114655A2 (en) 2014-01-21 2015-01-20 Modified release tablet of pregabalin
IN198MU2014 IN2014MU00198A (enrdf_load_html_response) 2014-01-21 2015-01-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN198MU2014 IN2014MU00198A (enrdf_load_html_response) 2014-01-21 2015-01-20

Publications (1)

Publication Number Publication Date
IN2014MU00198A true IN2014MU00198A (enrdf_load_html_response) 2015-08-28

Family

ID=53757862

Family Applications (1)

Application Number Title Priority Date Filing Date
IN198MU2014 IN2014MU00198A (enrdf_load_html_response) 2014-01-21 2015-01-20

Country Status (2)

Country Link
IN (1) IN2014MU00198A (enrdf_load_html_response)
WO (1) WO2015114655A2 (enrdf_load_html_response)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106606495A (zh) * 2015-10-27 2017-05-03 四川海思科制药有限公司 一种普瑞巴林缓释片药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
JP2011504491A (ja) * 2007-11-23 2011-02-10 ルピン・リミテッド プレガバリンの制御放出医薬組成物
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
US20130280324A1 (en) * 2010-09-17 2013-10-24 Panacea Biotec Ltd. Sustained release pharmaceutical compositions comprising pregabalin

Also Published As

Publication number Publication date
WO2015114655A2 (en) 2015-08-06
WO2015114655A3 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
PT3233493T (pt) Biotinta nanofibrilar de celulose para bioimpressão em 3d para cultura celular, aplicações de engenharia de tecidos e medicina regenerativa
MX2017004876A (es) Proceso para preparar un eritritol directamente comprimible y usos de este.
EP3102188A4 (en) Novel disintegration systems for pharmaceutical dosage forms
SG11201605633XA (en) Smoking article with liquid release component having frangible shell
PH12016501841A1 (en) Immunosuppressant formulation
IL247986A0 (en) A therapeutic regimen containing an immediate release dose of an s1p modulator
IL256299A (en) Immediate-release tablets containing drug and processes for creating the tablets
HUE054670T2 (hu) Módszer cachexia visszafordítására és túlélés megnövelésére egy GDF15 modulátor és egy rákellenes szer adagolásával
NZ725577A (en) Modified release coated capsules
IN2014DN06966A (enrdf_load_html_response)
NZ725578A (en) Modified release coated capsules
SG10201913394SA (en) Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof
GEP20197020B (en) Vortioxetine pyroglutamate
HK1248571A1 (zh) 用於多核苷酸转染的肽-多核苷酸复合物
MY181685A (en) Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
SG11201609948YA (en) Lobaplatin crystal, preparation method and pharmaceutical application
FR3018193B1 (fr) Comprime vaginal muco-adhesif a liberation prolongee
PH12016502272A1 (en) Ceritinib formulation
SG10201913366QA (en) Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof
EP3189853A4 (en) Immune-induction-promoting composition including nuclear receptor ligand, and vaccine pharmaceutical composition
IN2014MU00198A (enrdf_load_html_response)
SG10201913355RA (en) Pharmaceutical association for converting a neoplastic cell into a non-neoplastic cell and uses thereof
IN2014MU00215A (enrdf_load_html_response)
GEP20196989B (en) Pharmaceutical composition comprising bisoprolol and perindoril
UA118228C2 (uk) Засіб для лікування та профілактики кератокон'юнктивітних розладів